亚太地区旅行疫苗市场预测至 2028 年 - COVID-19 影响和按产品（甲型肝炎、乙型肝炎、脑膜炎球菌疫苗等）和应用（国内旅行和出境旅行）进行区域分析
No. of Pages: 124 | Report Code: BMIRE00025509 | Category: Life Sciences
No. of Pages: 124 | Report Code: BMIRE00025509 | Category: Life Sciences
对疫苗益处的认识不断提高是导致增长的主要因素该地区的旅行疫苗市场。大多数国家都强制针对各种传染病进行疫苗接种。然而，大多数低收入和中等收入国家缺乏对疫苗接种的认识。许多国家开展疫苗接种宣传活动。 2018年，西太平洋地区17个国家庆祝了“世界免疫周”。以“共同保护疫苗工作”为主题。此外，国际组织还向亚太地区的低收入和中等收入国家的儿童提供针对肺炎、HPV 感染和轮状病毒的疫苗。另一方面，疫苗接种意识也是发达国家公共卫生体系的重要组成部分。此类举措正在增加疫苗的免疫接种和生产，为市场提供增长机会。此外，它还将对人们进行有关旅行疫苗的教育。由于为了寻求更好的工作机会和健康而进行的跨地区旅行有所增加，国内和国际旅行者始终面临着感染传染病的风险，并可能在旅行之前或之后将其传播给其他人。因此，此类举措和计划正在为旅行疫苗创造一个范围，并在低收入和中等收入国家建立一个强劲的市场。
凭借新功能和技术，供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会推动亚太地区旅行疫苗市场的发展。预计亚太地区旅行疫苗市场在预测期内将以良好的复合年增长率增长。
亚太地区旅行疫苗市场细分 ;
亚太地区旅行疫苗市场分为产品、应用和国家。亚太地区旅行疫苗市场根据产品分为甲型肝炎、乙型肝炎、脑膜炎球菌疫苗等。 2021年，其他细分市场占据最大市场份额。亚太旅行疫苗市场根据应用分为国内旅行和出境旅行。 2021年，出境游细分市场占据最大市场份额。按国家/地区划分，亚太地区旅行疫苗市场分为澳大利亚、中国、印度、日本、韩国和亚太地区其他地区。
雅培；巴拉特生物技术公司；紧急生物解决方案公司；葛兰素史克公司；默克公司有限公司；诺华公司；辉瑞公司；和赛诺菲是该地区旅行疫苗市场的领先公司之一。
Strategic insights for Asia Pacific Travel Vaccines involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 486.56 Million |
| Market Size by 2028 | US$ 1,023.07 Million |
| Global CAGR (2021 - 2028) | 11.2% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 产品
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Travel Vaccines refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Travel Vaccines Market is valued at US$ 486.56 Million in 2021, it is projected to reach US$ 1,023.07 Million by 2028.
As per our report Asia Pacific Travel Vaccines Market, the market size is valued at US$ 486.56 Million in 2021, projecting it to reach US$ 1,023.07 Million by 2028. This translates to a CAGR of approximately 11.2% during the forecast period.
The Asia Pacific Travel Vaccines Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Travel Vaccines Market report:
The Asia Pacific Travel Vaccines Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Travel Vaccines Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Travel Vaccines Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Travel Vaccines Market
